Location History:
- Antwrep, BE (2016)
- Antwerp, BE (2015 - 2020)
- Beerse, BE (2019 - 2020)
Company Filing History:
5 out of 111 
4 out of 2,078 
3 out of 61 
Years Active: 2015-2020
Title: The Innovative Contributions of Ioannis Nicolaos Houpis
Introduction
Ioannis Nicolaos Houpis is a notable inventor based in Antwerp, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for therapeutic use. With a total of 12 patents to his name, Houpis has demonstrated a strong commitment to innovation and research.
Latest Patents
Among his latest patents, Houpis has developed Uracyl spirooxetane nucleosides. This invention relates to compounds that include various stereoisomers, as well as pharmaceutically acceptable salts or solvates. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions containing them, and their application in HCV therapy, either alone or in combination with other HCV inhibitors. Another significant patent involves a novel process for preparing compounds that inhibit sodium-dependent glucose transporter (SGLT) activity, which is present in the intestine or kidney.
Career Highlights
Houpis has worked with prominent companies in the pharmaceutical industry, including Janssen Sciences Ireland UC and Janssen Pharmaceutica NV. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Houpis has collaborated with esteemed colleagues such as Pierre Jean-Marie Bernard Raboisson and Tim Hugo Maria Jonckers. These collaborations have further enriched his research and innovation efforts.
Conclusion
Ioannis Nicolaos Houpis is a distinguished inventor whose work has significantly impacted the pharmaceutical field. His innovative patents and collaborations highlight his dedication to advancing medical science and improving therapeutic options.